Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NamePashun Int'l
Stock Code00574
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities我們是中國西南部的綜合醫藥公司,上游合併業務模式涵蓋醫藥行業價值鏈的主要階段,主要營運醫藥分銷、自營零售藥房及製藥三個業務分部。
Listing Date2015-06-19
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)香港灣仔港灣道6–8號瑞安中心26樓2601–2603室
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitepashun.com.cn
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 1.22 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueRMB 0.001 / shares
Offer Period2015-06-09 to 2015-06-12
Global Offering Shares250,000,000 shares
HK Public Offer Shares (Initial)25,000,000 shares (10.0%)
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)225,000,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO1,000,000,000 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 305,000,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 60.1M
Est. Threshold HK$ 9.69B
Analysis Result HK market cap below threshold, need +16039%

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利約人民幣46.1百萬元
Period-End Cash BalanceTo be extracted
Listing Expenses~HK$ 50,600,000
Listing Expenses / Funds Raised~16.59%
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 RMB
Income Statement
Item 201220132014
Profit for the year 9,30863,06946,129
Balance Sheet
Item 201220132014
Cash and cash equivalents 39,22765,37567,059
Trade and bills receivables 292,367350,609363,799
Inventories 67,87658,81769,128
Total current assets 432,646532,769575,181
Total assets 505,644687,189713,992
Total current liabilities 370,055484,500468,601
Total liabilities 433,029546,109532,712
Total equity 72,615141,080181,280
Equity attributable to owners 71,738140,204180,219
Interest-bearing borrowings 24,00075,00050,000
Cash Flow Statement
Item 201220132014
Net cash from operating activities -42,24292,22548,664
Net cash from investing activities -2,698-105,599-16,294
Net cash from financing activities 34,06739,935-30,933
Net increase in cash -10,87326,5611,437
Depreciation of PP&E 2,8743,7719,368
Amortisation of intangible assets 455522619
Purchase of PP&E -3,870-10,523-19,833
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 1.42
First Day OpenHK$ 1.2
First Day Change16.39%
First Day Volume206913000.0
First Day Turnover274725000.0
Use of Proceeds
1、約48.6%,或123.6百萬港元,預計用作公司于成都的計劃物流中心,其中約49.5%,或60.0百萬港元,預計用作建設設施及裝修租賃物業,及約50.5%,或61.3百萬港元,預計用作購置及安裝設備及軟件; 2、約46.6%,或118.5百萬港元,預計主要用作收購或成立自營零售藥店; 3、約4.8%,或12.2百萬港元,預計用作撥支營運資金及一般企業用途。

Underwriting Syndicate

Sole Sponsor (1)
CHINA EVERBRIGHT CAPITAL LIMITED CE ACE409
Overall Coordinators (1)
CHINA EVERBRIGHT SECURITIES (HK) LIMITED CE AAW536
Joint Bookrunners (1)
CHINA EVERBRIGHT SECURITIES (HK) LIMITED CE AAW536
Joint Lead Managers (1)
CHINA EVERBRIGHT SECURITIES (HK) LIMITED CE AAW536

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
Chairman陳燕飛—
Company Secretary雷美嘉—
No director data available.

Major Shareholders

Major Shareholders & Holdings陳先生及嘉寶上市後持股約48.80%;Li Ho Tan先生約23.05%;晉鼎及Cheung Chi Mang先生約19.30%。
About this page

This page shows Pashun Int'l (00574) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect